Thus the importance of our new findings lies in the unequivocal demonstration of tau pathology in the brains of patients with Huntington’s disease and the effect of MAPT H2 haplotype on cognitive decline in a large cohort of patients. The gene discussed is MAPT; the disease is Huntington disease.